Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for SMAD4
Z-value: 1.48
Motif logo
Transcription factors associated with SMAD4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SMAD4
|
ENSG00000141646.9 | SMAD family member 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SMAD4 | hg19_v2_chr18_+_48556470_48556640 | -0.71 | 1.2e-05 | Click! |
Activity profile of SMAD4 motif
Sorted Z-values of SMAD4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51456321 | 7.65 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51456344 | 7.07 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51456198 | 4.90 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr1_+_152956549 | 3.72 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
| chr19_-_11688447 | 3.13 |
ENST00000590420.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
| chrX_-_48328551 | 3.08 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr1_-_28520447 | 3.05 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
| chrX_-_48328631 | 3.00 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr1_+_45212074 | 3.00 |
ENST00000372217.1
|
KIF2C
|
kinesin family member 2C |
| chr5_+_148521381 | 2.99 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr2_-_113594279 | 2.99 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr1_-_24469602 | 2.99 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
| chr2_-_31360887 | 2.97 |
ENST00000420311.2
ENST00000356174.3 ENST00000324589.5 |
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
| chr5_-_39219705 | 2.97 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
| chr19_-_11688500 | 2.88 |
ENST00000433365.2
|
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr1_+_45212051 | 2.85 |
ENST00000372222.3
|
KIF2C
|
kinesin family member 2C |
| chr5_+_148521046 | 2.69 |
ENST00000326685.7
ENST00000356541.3 ENST00000309868.7 |
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr1_+_152486950 | 2.68 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
| chr10_+_75670862 | 2.65 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
| chr7_+_48128316 | 2.64 |
ENST00000341253.4
|
UPP1
|
uridine phosphorylase 1 |
| chr5_+_148521136 | 2.64 |
ENST00000506113.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr7_+_48128194 | 2.64 |
ENST00000416681.1
ENST00000331803.4 ENST00000432131.1 |
UPP1
|
uridine phosphorylase 1 |
| chr5_-_39219641 | 2.61 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
| chr22_+_30752606 | 2.57 |
ENST00000399824.2
ENST00000405659.1 ENST00000338306.3 |
CCDC157
|
coiled-coil domain containing 157 |
| chr11_-_107729887 | 2.52 |
ENST00000525815.1
|
SLC35F2
|
solute carrier family 35, member F2 |
| chr1_-_28520384 | 2.46 |
ENST00000305392.3
|
PTAFR
|
platelet-activating factor receptor |
| chr17_+_42081914 | 2.41 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr19_-_43032532 | 2.39 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| chr2_+_30454390 | 2.37 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr17_-_7297519 | 2.34 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr2_-_208030647 | 2.29 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr22_-_37880543 | 2.29 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr10_+_88718397 | 2.28 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr10_+_102891048 | 2.26 |
ENST00000467928.2
|
TLX1
|
T-cell leukemia homeobox 1 |
| chr10_+_88718314 | 2.18 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr12_-_54813229 | 2.17 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr22_+_31488433 | 2.16 |
ENST00000455608.1
|
SMTN
|
smoothelin |
| chr9_+_140119618 | 2.16 |
ENST00000359069.2
|
C9orf169
|
chromosome 9 open reading frame 169 |
| chr15_+_40453204 | 2.14 |
ENST00000287598.6
ENST00000412359.3 |
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B |
| chr12_-_57634475 | 2.11 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr9_-_139891165 | 2.10 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr19_-_49015050 | 2.05 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr1_+_203595903 | 2.04 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr22_-_37823468 | 2.04 |
ENST00000402918.2
|
ELFN2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
| chr2_+_33359687 | 2.03 |
ENST00000402934.1
ENST00000404525.1 ENST00000407925.1 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr12_-_8815215 | 2.03 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr19_-_41859814 | 2.03 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
| chr15_+_81071684 | 2.02 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
| chrX_-_153599578 | 2.02 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
| chr1_+_203595689 | 2.00 |
ENST00000357681.5
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr12_-_8815299 | 1.99 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
| chr17_-_76899275 | 1.99 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
| chr4_-_111119804 | 1.96 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr17_+_74372662 | 1.94 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
| chr19_+_35645618 | 1.94 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr2_+_33359646 | 1.91 |
ENST00000390003.4
ENST00000418533.2 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr17_+_74381343 | 1.91 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
| chr15_-_89764929 | 1.88 |
ENST00000268125.5
|
RLBP1
|
retinaldehyde binding protein 1 |
| chr21_+_30502806 | 1.87 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr15_+_67420441 | 1.82 |
ENST00000558894.1
|
SMAD3
|
SMAD family member 3 |
| chr2_+_113735575 | 1.76 |
ENST00000376489.2
ENST00000259205.4 |
IL36G
|
interleukin 36, gamma |
| chr1_-_9189229 | 1.76 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr7_-_107642348 | 1.74 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr2_-_70780572 | 1.74 |
ENST00000450929.1
|
TGFA
|
transforming growth factor, alpha |
| chr2_-_228028829 | 1.73 |
ENST00000396625.3
ENST00000329662.7 |
COL4A4
|
collagen, type IV, alpha 4 |
| chrX_+_135279179 | 1.72 |
ENST00000370676.3
|
FHL1
|
four and a half LIM domains 1 |
| chr14_-_24732368 | 1.71 |
ENST00000544573.1
|
TGM1
|
transglutaminase 1 |
| chr11_-_61647935 | 1.67 |
ENST00000531956.1
|
FADS3
|
fatty acid desaturase 3 |
| chr19_+_42301079 | 1.67 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
| chr19_-_51141196 | 1.66 |
ENST00000338916.4
|
SYT3
|
synaptotagmin III |
| chr16_+_23690138 | 1.62 |
ENST00000300093.4
|
PLK1
|
polo-like kinase 1 |
| chr3_-_48632593 | 1.61 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
| chr14_-_24732403 | 1.60 |
ENST00000206765.6
|
TGM1
|
transglutaminase 1 |
| chr20_+_30598231 | 1.59 |
ENST00000300415.8
ENST00000262659.8 |
CCM2L
|
cerebral cavernous malformation 2-like |
| chrX_-_153602991 | 1.58 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
| chr12_+_75874460 | 1.57 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr9_-_123639445 | 1.56 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
| chr1_+_26605618 | 1.55 |
ENST00000270792.5
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
| chr3_+_50316458 | 1.55 |
ENST00000316436.3
|
LSMEM2
|
leucine-rich single-pass membrane protein 2 |
| chr6_-_112080256 | 1.55 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr5_+_150404904 | 1.55 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr20_+_60174827 | 1.53 |
ENST00000543233.1
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal) |
| chr16_+_66638616 | 1.52 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr1_-_110283138 | 1.51 |
ENST00000256594.3
|
GSTM3
|
glutathione S-transferase mu 3 (brain) |
| chr2_-_9563575 | 1.51 |
ENST00000488451.1
ENST00000238091.4 ENST00000355346.4 |
ITGB1BP1
|
integrin beta 1 binding protein 1 |
| chr16_-_46655538 | 1.50 |
ENST00000303383.3
|
SHCBP1
|
SHC SH2-domain binding protein 1 |
| chr12_-_49365501 | 1.50 |
ENST00000403957.1
ENST00000301061.4 |
WNT10B
|
wingless-type MMTV integration site family, member 10B |
| chr18_-_33077556 | 1.49 |
ENST00000589273.1
ENST00000586489.1 |
INO80C
|
INO80 complex subunit C |
| chr2_+_102456277 | 1.48 |
ENST00000421882.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr11_+_72929402 | 1.45 |
ENST00000393596.2
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
| chr22_+_44319648 | 1.45 |
ENST00000423180.2
|
PNPLA3
|
patatin-like phospholipase domain containing 3 |
| chr1_+_11751748 | 1.43 |
ENST00000294485.5
|
DRAXIN
|
dorsal inhibitory axon guidance protein |
| chr19_-_51017881 | 1.43 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
| chr10_+_50822480 | 1.42 |
ENST00000455728.2
|
CHAT
|
choline O-acetyltransferase |
| chr19_-_44285401 | 1.42 |
ENST00000262888.3
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| chr2_-_71062938 | 1.42 |
ENST00000410009.3
|
CD207
|
CD207 molecule, langerin |
| chr17_-_34122596 | 1.41 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
| chr1_+_155178518 | 1.41 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
| chr7_-_142120321 | 1.38 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
| chr11_+_35211429 | 1.37 |
ENST00000525688.1
ENST00000278385.6 ENST00000533222.1 |
CD44
|
CD44 molecule (Indian blood group) |
| chr10_-_75193308 | 1.36 |
ENST00000299432.2
|
MSS51
|
MSS51 mitochondrial translational activator |
| chr16_+_68877496 | 1.36 |
ENST00000261778.1
|
TANGO6
|
transport and golgi organization 6 homolog (Drosophila) |
| chr11_+_35211511 | 1.35 |
ENST00000524922.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr20_-_33880204 | 1.34 |
ENST00000374408.3
|
FAM83C
|
family with sequence similarity 83, member C |
| chr3_-_48594248 | 1.34 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
| chr1_+_153388993 | 1.33 |
ENST00000368729.4
|
S100A7A
|
S100 calcium binding protein A7A |
| chr1_+_155178481 | 1.32 |
ENST00000368376.3
|
MTX1
|
metaxin 1 |
| chr7_+_24613034 | 1.32 |
ENST00000409761.1
ENST00000396475.2 |
MPP6
|
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
| chr17_-_39780819 | 1.31 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
| chr2_-_27718052 | 1.31 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
| chr20_+_42984330 | 1.30 |
ENST00000316673.4
ENST00000609795.1 ENST00000457232.1 ENST00000609262.1 |
HNF4A
|
hepatocyte nuclear factor 4, alpha |
| chr22_+_44319619 | 1.30 |
ENST00000216180.3
|
PNPLA3
|
patatin-like phospholipase domain containing 3 |
| chr20_-_23967432 | 1.30 |
ENST00000286890.4
ENST00000278765.4 |
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
| chr19_+_49055332 | 1.29 |
ENST00000201586.2
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1 |
| chr3_+_154797877 | 1.29 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
| chr14_+_65171315 | 1.29 |
ENST00000394691.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr12_+_75874580 | 1.28 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr9_+_126118449 | 1.28 |
ENST00000359999.3
ENST00000373631.3 |
CRB2
|
crumbs homolog 2 (Drosophila) |
| chr3_-_47950745 | 1.26 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
| chr4_+_154073469 | 1.26 |
ENST00000441616.1
|
TRIM2
|
tripartite motif containing 2 |
| chr12_-_99038732 | 1.26 |
ENST00000393042.3
ENST00000420861.1 ENST00000299157.4 ENST00000342502.2 |
IKBIP
|
IKBKB interacting protein |
| chr14_-_91720224 | 1.26 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
| chr17_-_7297833 | 1.24 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr1_+_209859510 | 1.24 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr8_-_125486755 | 1.23 |
ENST00000499418.2
ENST00000530778.1 |
RNF139-AS1
|
RNF139 antisense RNA 1 (head to head) |
| chr2_-_112237835 | 1.23 |
ENST00000442293.1
ENST00000439494.1 |
MIR4435-1HG
|
MIR4435-1 host gene (non-protein coding) |
| chr3_+_130569592 | 1.22 |
ENST00000533801.2
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
| chr11_-_568369 | 1.21 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr9_+_34990219 | 1.21 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
| chr6_-_131291572 | 1.20 |
ENST00000529208.1
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr1_+_183155373 | 1.20 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr20_-_6103666 | 1.20 |
ENST00000536936.1
|
FERMT1
|
fermitin family member 1 |
| chr14_-_106830057 | 1.19 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr19_-_44031341 | 1.18 |
ENST00000600651.1
|
ETHE1
|
ethylmalonic encephalopathy 1 |
| chr15_+_75182346 | 1.18 |
ENST00000569931.1
ENST00000352410.4 ENST00000566377.1 ENST00000569233.1 ENST00000567132.1 ENST00000564633.1 ENST00000568907.1 ENST00000563422.1 ENST00000564003.1 ENST00000562800.1 ENST00000563786.1 ENST00000535694.1 ENST00000323744.6 ENST00000568828.1 ENST00000562606.1 ENST00000565576.1 ENST00000567570.1 |
MPI
|
mannose phosphate isomerase |
| chr20_+_42965626 | 1.18 |
ENST00000217043.2
|
R3HDML
|
R3H domain containing-like |
| chr1_+_156254070 | 1.17 |
ENST00000405535.2
ENST00000456810.1 |
TMEM79
|
transmembrane protein 79 |
| chr7_+_134551583 | 1.17 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
| chr19_-_43702231 | 1.17 |
ENST00000597374.1
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr14_+_20937538 | 1.17 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
| chr22_-_30234218 | 1.17 |
ENST00000307790.3
ENST00000542393.1 ENST00000397771.2 |
ASCC2
|
activating signal cointegrator 1 complex subunit 2 |
| chr12_-_6960407 | 1.16 |
ENST00000540683.1
ENST00000229265.6 ENST00000535406.1 ENST00000422785.3 |
CDCA3
|
cell division cycle associated 3 |
| chr2_+_113816685 | 1.16 |
ENST00000393200.2
|
IL36RN
|
interleukin 36 receptor antagonist |
| chr17_-_43487741 | 1.15 |
ENST00000455881.1
|
ARHGAP27
|
Rho GTPase activating protein 27 |
| chr12_+_47473369 | 1.15 |
ENST00000546455.1
|
PCED1B
|
PC-esterase domain containing 1B |
| chr12_+_75874984 | 1.15 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chrX_-_48815633 | 1.15 |
ENST00000428668.2
|
OTUD5
|
OTU domain containing 5 |
| chr8_-_145028013 | 1.14 |
ENST00000354958.2
|
PLEC
|
plectin |
| chr3_+_39371191 | 1.14 |
ENST00000326306.4
|
CCR8
|
chemokine (C-C motif) receptor 8 |
| chr7_-_23510086 | 1.13 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
| chr19_-_44031375 | 1.13 |
ENST00000292147.2
|
ETHE1
|
ethylmalonic encephalopathy 1 |
| chr16_+_31483374 | 1.12 |
ENST00000394863.3
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
| chr19_-_50143452 | 1.12 |
ENST00000246792.3
|
RRAS
|
related RAS viral (r-ras) oncogene homolog |
| chr17_+_41476327 | 1.12 |
ENST00000320033.4
|
ARL4D
|
ADP-ribosylation factor-like 4D |
| chr22_-_21579843 | 1.11 |
ENST00000405188.4
|
GGT2
|
gamma-glutamyltransferase 2 |
| chr13_-_21750659 | 1.10 |
ENST00000400018.3
ENST00000314759.5 |
SKA3
|
spindle and kinetochore associated complex subunit 3 |
| chr17_+_9066252 | 1.10 |
ENST00000436734.1
|
NTN1
|
netrin 1 |
| chr19_+_54371114 | 1.10 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr19_-_14629224 | 1.10 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr1_+_110210644 | 1.09 |
ENST00000369831.2
ENST00000442650.1 ENST00000369827.3 ENST00000460717.3 ENST00000241337.4 ENST00000467579.3 ENST00000414179.2 ENST00000369829.2 |
GSTM2
|
glutathione S-transferase mu 2 (muscle) |
| chr20_+_31619454 | 1.09 |
ENST00000349552.1
|
BPIFB6
|
BPI fold containing family B, member 6 |
| chr6_+_43738444 | 1.09 |
ENST00000324450.6
ENST00000417285.2 ENST00000413642.3 ENST00000372055.4 ENST00000482630.2 ENST00000425836.2 ENST00000372064.4 ENST00000372077.4 ENST00000519767.1 |
VEGFA
|
vascular endothelial growth factor A |
| chr3_-_195619579 | 1.09 |
ENST00000428187.1
|
TNK2
|
tyrosine kinase, non-receptor, 2 |
| chr6_+_12290586 | 1.08 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
| chr6_-_41863098 | 1.08 |
ENST00000373006.1
|
USP49
|
ubiquitin specific peptidase 49 |
| chr3_-_42743006 | 1.08 |
ENST00000310417.5
|
HHATL
|
hedgehog acyltransferase-like |
| chr1_-_214638146 | 1.08 |
ENST00000543945.1
|
PTPN14
|
protein tyrosine phosphatase, non-receptor type 14 |
| chr1_-_149908710 | 1.08 |
ENST00000439741.2
ENST00000361405.6 ENST00000406732.3 |
MTMR11
|
myotubularin related protein 11 |
| chr15_-_70388943 | 1.06 |
ENST00000559048.1
ENST00000560939.1 ENST00000440567.3 ENST00000557907.1 ENST00000558379.1 ENST00000451782.2 ENST00000559929.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr15_-_70388599 | 1.05 |
ENST00000560996.1
ENST00000558201.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr19_-_51017127 | 1.05 |
ENST00000389208.4
|
ASPDH
|
aspartate dehydrogenase domain containing |
| chr1_-_201368707 | 1.05 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
| chr9_+_75263565 | 1.04 |
ENST00000396237.3
|
TMC1
|
transmembrane channel-like 1 |
| chr22_-_24641027 | 1.04 |
ENST00000398292.3
ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5
|
gamma-glutamyltransferase 5 |
| chr9_-_21305312 | 1.03 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
| chr7_+_86274145 | 1.03 |
ENST00000439827.1
ENST00000394720.2 ENST00000421579.1 |
GRM3
|
glutamate receptor, metabotropic 3 |
| chr1_+_152691998 | 1.03 |
ENST00000368775.2
|
C1orf68
|
chromosome 1 open reading frame 68 |
| chr4_+_187187098 | 1.03 |
ENST00000403665.2
ENST00000264692.4 |
F11
|
coagulation factor XI |
| chr6_-_35656685 | 1.02 |
ENST00000539068.1
ENST00000540787.1 |
FKBP5
|
FK506 binding protein 5 |
| chr3_+_111718173 | 1.02 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
| chr12_-_53207842 | 1.01 |
ENST00000458244.2
|
KRT4
|
keratin 4 |
| chr7_-_107443652 | 1.01 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
| chr9_+_35673853 | 1.00 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
| chr16_+_3070356 | 1.00 |
ENST00000341627.5
ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
| chr19_-_40324767 | 1.00 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr3_-_12800751 | 1.00 |
ENST00000435218.2
ENST00000435575.1 |
TMEM40
|
transmembrane protein 40 |
| chr5_+_176784837 | 0.99 |
ENST00000408923.3
|
RGS14
|
regulator of G-protein signaling 14 |
| chr16_+_66638003 | 0.99 |
ENST00000562357.1
ENST00000360086.4 ENST00000562707.1 ENST00000361909.4 ENST00000460097.1 ENST00000565666.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr1_-_24127256 | 0.99 |
ENST00000418277.1
|
GALE
|
UDP-galactose-4-epimerase |
| chr20_+_49126881 | 0.98 |
ENST00000371621.3
ENST00000541713.1 |
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1 |
| chrX_-_15683147 | 0.98 |
ENST00000380342.3
|
TMEM27
|
transmembrane protein 27 |
| chr2_+_174219548 | 0.98 |
ENST00000347703.3
ENST00000392567.2 ENST00000306721.3 ENST00000410101.3 ENST00000410019.3 |
CDCA7
|
cell division cycle associated 7 |
| chr17_-_39637392 | 0.98 |
ENST00000246639.2
ENST00000393989.1 |
KRT35
|
keratin 35 |
| chr15_-_74504560 | 0.98 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
| chr15_-_83953466 | 0.97 |
ENST00000345382.2
|
BNC1
|
basonuclin 1 |
| chr17_+_15603447 | 0.97 |
ENST00000395893.2
|
ZNF286A
|
Homo sapiens zinc finger protein 286A (ZNF286A), transcript variant 6, mRNA. |
| chr11_+_117070037 | 0.97 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
| chr10_-_90712520 | 0.96 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
| chr11_-_64851496 | 0.95 |
ENST00000404147.3
ENST00000275517.3 |
CDCA5
|
cell division cycle associated 5 |
| chr12_-_6961050 | 0.95 |
ENST00000538862.2
|
CDCA3
|
cell division cycle associated 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SMAD4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 19.6 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.8 | 5.5 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.3 | 4.0 | GO:1903248 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.3 | 5.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.3 | 3.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.2 | 6.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.1 | 3.3 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.0 | 3.0 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.9 | 2.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.8 | 2.5 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.8 | 0.8 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.8 | 2.4 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) insulin catabolic process(GO:1901143) |
| 0.7 | 4.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.7 | 2.0 | GO:1900126 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.6 | 1.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.6 | 1.3 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.6 | 5.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.6 | 1.7 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.5 | 2.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.5 | 1.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 | 1.5 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.5 | 1.5 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 0.5 | 2.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 6.4 | GO:0015816 | glycine transport(GO:0015816) |
| 0.4 | 0.9 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
| 0.4 | 4.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 | 2.6 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 | 1.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 0.4 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.4 | 1.2 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.4 | 2.3 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.4 | 1.8 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.4 | 0.4 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.4 | 1.1 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.4 | 1.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.3 | 2.1 | GO:0042335 | cuticle development(GO:0042335) |
| 0.3 | 1.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.3 | 1.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.3 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 1.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.3 | 1.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 | 2.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 | 5.7 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.3 | 2.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.3 | 1.2 | GO:0042640 | anagen(GO:0042640) regulation of anagen(GO:0051884) |
| 0.3 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 1.4 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.3 | 1.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.3 | 1.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 | 2.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 1.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 | 0.8 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 | 2.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.3 | 0.5 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.3 | 0.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.3 | 1.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.3 | 0.5 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.3 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 1.3 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular response to UV-A(GO:0071492) |
| 0.3 | 1.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.2 | 1.7 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.2 | 0.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.2 | 2.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 | 1.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 0.7 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.2 | 0.7 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 0.2 | 2.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 0.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 1.3 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) response to cortisol(GO:0051414) apoptotic process involved in luteolysis(GO:0061364) |
| 0.2 | 1.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.0 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.2 | 1.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.2 | 1.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 | 1.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 1.0 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.2 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.2 | 0.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 0.8 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 | 2.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 0.8 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 | 0.6 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.2 | 0.6 | GO:0050894 | determination of affect(GO:0050894) |
| 0.2 | 1.7 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.2 | 0.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 0.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.2 | 0.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 0.9 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.2 | 0.5 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.5 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 0.2 | 0.9 | GO:0010193 | response to ozone(GO:0010193) |
| 0.2 | 0.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 | 1.2 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.2 | 1.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 1.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.2 | 0.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 0.5 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 | 0.5 | GO:0033043 | regulation of organelle organization(GO:0033043) |
| 0.2 | 0.5 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 | 0.5 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 | 1.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.2 | 0.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 1.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 0.9 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 | 0.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.2 | 0.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.2 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.2 | 0.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 1.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 2.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 1.4 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 0.9 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.1 | 1.4 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.1 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.1 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 1.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 0.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.4 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.1 | 0.6 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.1 | 0.7 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.3 | GO:0002285 | lymphocyte activation involved in immune response(GO:0002285) |
| 0.1 | 0.4 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 | 2.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 2.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 2.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 2.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 2.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.1 | 0.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.1 | 1.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 5.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.1 | 0.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 1.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.1 | 5.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 1.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 | 0.4 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 | 1.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.3 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 | 0.3 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.3 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.1 | 0.3 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) detection of chemical stimulus involved in sensory perception of pain(GO:0050968) response to capsazepine(GO:1901594) |
| 0.1 | 0.4 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 | 1.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.3 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.1 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.6 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.1 | 0.3 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.1 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 0.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 | 1.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.1 | 0.4 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 | 0.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 1.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 | 0.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.4 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.1 | 0.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 4.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.4 | GO:0045914 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.1 | 0.4 | GO:1903971 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 | 0.3 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.3 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 | 0.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 10.2 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.1 | 2.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 0.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 | 10.1 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 1.6 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.1 | 0.3 | GO:2001137 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) positive regulation of endocytic recycling(GO:2001137) |
| 0.1 | 0.8 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 | 0.5 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.8 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 1.0 | GO:0030903 | notochord development(GO:0030903) |
| 0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 0.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.1 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 1.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.1 | 0.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 1.0 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 | 1.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.4 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 0.2 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.8 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 | 0.6 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 0.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 2.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 1.5 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.1 | 0.2 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.1 | 2.1 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 1.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.1 | 1.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 1.1 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 0.2 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 1.1 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 0.3 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.1 | 1.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.1 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.1 | 0.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 0.8 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.0 | 0.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.0 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.4 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.0 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.0 | 0.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.0 | 0.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.0 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.0 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.2 | GO:0048609 | multicellular organismal reproductive process(GO:0048609) |
| 0.0 | 0.7 | GO:0060324 | face development(GO:0060324) |
| 0.0 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.4 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.0 | 0.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.0 | 0.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 | 2.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 2.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 1.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.0 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
| 0.0 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.0 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.0 | 0.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 | 0.1 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.0 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.0 | 0.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.0 | 0.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 | 2.7 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.0 | 1.4 | GO:0071174 | mitotic spindle checkpoint(GO:0071174) |
| 0.0 | 0.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 | 0.5 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.0 | 2.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 1.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
| 0.0 | 0.5 | GO:0006935 | chemotaxis(GO:0006935) taxis(GO:0042330) |
| 0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.0 | 1.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.0 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 | 0.1 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.0 | 0.6 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 0.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 1.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 1.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 1.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 1.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.3 | GO:0010737 | protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.0 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.0 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.2 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 1.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
| 0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.0 | 0.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.0 | 1.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 | 0.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.0 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.0 | 0.2 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 | 1.1 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 0.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.0 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.6 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 | 0.5 | GO:0035637 | multicellular organismal signaling(GO:0035637) |
| 0.0 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.3 | GO:0007015 | actin filament organization(GO:0007015) |
| 0.0 | 1.2 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.0 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.1 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.0 | 0.8 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.5 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.3 | GO:1901343 | negative regulation of angiogenesis(GO:0016525) negative regulation of vasculature development(GO:1901343) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 0.7 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 1.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
| 0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 | 0.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.0 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.0 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.0 | 0.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.0 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.0 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
| 0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.0 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 | 0.0 |